Exhibit 107
Calculation of Filing Fee Table
Form F-3
(Form Type)
Autolus Therapeutics plc
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1)(2) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(6) | |||||||
Equity | American Depositary Shares (ADSs) | 457(c) | 21,250,917 | $4.23(3) | $89,785,124.33 | $0.0000927 | $8,323.08 | |||||||
Total Offering Amounts | $89,785,124.33 | — | ||||||||||||
Net Fee Due | $8,323.08 |
(1) | These shares consist of (i) 17,985,611 ADSs and (ii) an aggregate of 3,265,306 ADSs that are issuable upon the exercise of outstanding warrants to purchase our ADSs held by the selling securityholders. |
(2) | Pursuant to Rule 416 under the Securities Act, the ADSs being registered hereunder include such indeterminate number of ordinary shares as may be issuable with respect to the ADSs being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
(3) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended. The calculation of the proposed maximum aggregate offering price of the ADSs is based on the average of the high and low price for the common shares on April 12, 2022, as reported on the Nasdaq Global Select Market. |